Taking Control of Menopause

Monica Molenaar, co-founder and co-CEO, and Dr. Sharon Malone, certified national menopause practitioner and Medical Director from Alloy Women’s Health, Inc. discuss menopause and the health issues surrounding menopausal and post-menopausal women. They recommend a three-pronged approach that will offer women the best ways to make informed decisions to address their individual concerns about menopause and take back control of their health. 

Read More

Personal Story From an Allergy Safety Advocate

Thomas Silvera, allergy safety advocate and founder of the Elijah-Alavi Foundation shares his personal story about loss following the death of his three-year-old son who passed away at daycare after eating a grilled cheese sandwich. Following Elijah’s passing, Thomas and his family turned their pain into passion by advocating for anaphylaxis awareness and educating about the importance of having an allergic emergency plan. 

Read More

The FDA’s “Project Optimus” and Oncology Drugs

Julie Bullock, VP, Global Head of Clinical Pharmacology and Translational Medicine at Certara discusses the FDA’s Oncology Center of Excellence’s new initiative called “Project Optimus” which addresses issues relating to dose optimization in clinical trials assessing the safety and efficacy of oncology drugs. She talks about how the initiative may affect the current oncology drug pipeline and whether it may lead to the FDA making other changes in the oncology clinical trial space. For additional information, read more here.

Read More

The Impact of COVID-19 on Home and Community-Based Services Providers

Greg Strobel, CEO of HHAeXchange, the leading provider of homecare management solutions for payers, providers, and state Medicaid agencies, discusses the growth in demand for homecare services as a result of the pandemic, how technology can be leveraged to further ensure ongoing effective and consistent quality of homecare, and how to recruit and retain home caregivers in the era of the Great Resignation as demand for homecare continues to increase.  

Read More

Third Annual Incyte Ingenuity Awards Program

Incyte is now accepting entries for the third annual Incyte Ingenuity Awards Program, which aims to foster collaboration to develop novel solutions that support those living with graft-versus-host disease (GVHD), a rare condition that occurs when donor stem cells attack the transplant’s recipient’s organs, leading to significant morbidity and mortality. Meredith Cow​den, MA, LPCC-S, Incyte Ingenuity Awards judge and founder of The Meredith A. Cowden Foundation discusses GVHD, struggles faced by those impacted, and how this award can give the GVHD community hope for their future beyond this devastating disease. ​The awards will fund two novel initiatives, awarding up to $100,000 and $35,000, respectively, to support projects of different scales. Applications are due June 24, 2022, and can be submitted online at Incyte Ingenuity Awards Program

Read More

RetiSpec – Hyperspectral Retinal Imaging and AI to Diagnose Alzheimer’s Disease

Catherine Bornbaum, PhD, MBA, Head of Clinical Operations and Partnerships at RetiSpec discusses using hyperspectral retinal imaging and artificial intelligence to diagnose Alzheimer’s disease before the onset of symptoms. RetiSpec’s proprietary technology integrates seamlessly with an optometrist’s camera creating a new workflow from optometrist to neurologist. It provides a whole picture of disease diagnosis, is much cheaper than current methods, noninvasive, and will be of great value to Pharma as they rely on early diagnosis to recruit patients for Alzheimer’s clinical trials. 

Read More

Psychedelics Today – Vital – Psychedelics Training Program

David Drapkin, LCSW, discusses Vital, a holistic, immersive, 12-month program launched by Psychedelics Today that is designed for medical professionals, psychotherapists, and health practitioners incorporating psychedelics into their existing practices. The program is delivered and developed with world-leading academic and clinical researchers, therapists, and physicians.​ ​As a thought leader in the field of behavioral health and psychedelic therapy, David envisions a future where psychedelics play a central role in redefining true wellness.

Read More